Alkalon is a privately-owned Specialty Pharma company focused on developing and commercializing medicated chewing gum formulations. The company is working in partnership with large pharmaceutical companies on dosage form development projects and has its own portfolio of nicotine gums approved for smoking cessation and smoking reduction. Alkalon’s in-house R&D activities take place in a small non-GMP laboratory and all non-core activities are outsourced.
Looking for a particular Alkalon A/S employee's phone or email?
The Alkalon A/S annual revenue was $2 million in 2026.
Kristian Uggerhoj is the CEO of Alkalon A/S.
5 people are employed at Alkalon A/S.
Alkalon A/S is based in København V, Capital Region.
The NAICS codes for Alkalon A/S are [3254, 325, 32541, 32].
The SIC codes for Alkalon A/S are [28, 283].